Dr. Gold is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Gold is Director of Clinical Research and the Program Leader for the Gastrointestinal (GI) Oncology Program at the Swedish Cancer Institute in Seattle, Washington. In 1991, Dr. Gold obtained his degree in medicine with a distinction in research at the University of Miami School of Medicine in Florida. He then completed an internal medicine internship and residency at the University of Washington. Dr. Gold received the Amgen Oncology Fellowship Award while he was training in medical oncology at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. Presently, he is board certified in medical oncology. Dr. Gold’s clinical investigations on GI tumors, and particularly colorectal cancer treatment, can be found in peer-reviewed publications like the Journal of Clinical Oncology, Seminars in Oncology, and Cancer Investigation. Furthermore, he currently serves as a member of the NCI Colon Task Force, and the Southwest Oncology Group, where he serves as the subcommittee co-chair for colon cancer. In his free time, Dr. Gold enjoys photography and spending time with his wife and three sons. Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome.

Dr. Mehta is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He enjoys working with patients and family members. There are a wide variety of treatment options available for nearly every patient, so it is important to spend as much time as is needed in order to weight the benefits and risks to any particular approach. He feels that it is important that communication is open and honest. The goals of treatment, whether it is going for cure or maximizing quality of life should be openly discussed and re-discussed as the need arises. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Anal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members. Dr. Sui is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma.

"Dr. Evan Ong most recently received the 2023 Cancer Surgery Top Doc designation and has received the Seattle Top Doc award for multiple consecutive years. Dr. Ong's clinical practice focuses on the treatment of all gastrointestinal cancers with particular interest in treatment options for pancreatico-biliary cancers as well as regional and metastatic disease. He offers state-of-the-art treatment including minimally invasive and robotic surgery for hepatic and pancreatic tumors, microwave and bipolar radiofrequency ablation, irreversible electroporation (Nano-knife) as well as Hyperthermic Intraperitoneal Chemoperfusion (HIPEC), a treatment option for cancers that have disseminated to the peritoneal cavity. Dr. Ong's philosophy of care is ""Qui Audet...Cura"" - ""Who Dares...Cures.""". Dr. Ong is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Pancreatic Cancer, Familial Colorectal Cancer, Pseudomyxoma Peritonei, Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy.

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Nerve Decompression, and Endoscopy.

Michael Richardson is a Radiologist in Seattle, Washington. Dr. Richardson is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Rhabdomyosarcoma Embryonal, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma, and Rhabdoid Tumor Predisposition Syndrome.

Andrew Howlett is a General Surgeon and an Orthopedics provider in Spokane, Washington. Dr. Howlett is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Epithelioid Sarcoma, Rhabdomyosarcoma Embryonal, Undifferentiated Pleomorphic Sarcoma, Hip Replacement, and Knee Replacement. Dr. Howlett is currently accepting new patients.

Puneet Bhargava is a Radiologist in Seattle, Washington. Dr. Bhargava is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Jaundice, Undifferentiated Pleomorphic Sarcoma, Upper Tract Urothelial Carcinoma (UTUC), and WT1-Related Wilms Tumor Syndromes.

Carolyn Wang is a Radiologist in Seattle, Washington. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, and Penectomy.

Majid Chalian is a Radiologist in Seattle, Washington. Dr. Chalian is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Mononeuritis Multiplex, Femoral Nerve Dysfunction, Accessory Deep Peroneal Nerve, Liposarcoma, and Tenotomy.

Felix Chew is a Radiologist in Seattle, Washington. Dr. Chew has been practicing medicine for over 47 years and is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Rhabdomyosarcoma Embryonal, Undifferentiated Pleomorphic Sarcoma, Rhizarthrosis, Rhabdomyosarcoma, and Bone Graft.

Robert Randolph is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Randolph is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.

Dr. Lechner is a graduate of the University of California at Los Angeles School of Medicine. He completed his oncology and hematology training at Oregon Health & Science University in Portland. Dr. Lechner is board certified in medical oncology and internal medicine. Dr. Lechner is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Waldenstrom Macroglobulinemia.

Dr. McCormick sees patient education as an important part of her job. “I want each of my patients to understand their diagnosis and treatment options so that together we can formulate a plan tailored to their unique goals and priorities.” Dr. McCormick also believes in ensuring that her patients have access to the most state-of-the-art medical care, including the option of participating in promising clinical trials. Finally, Dr. McCormick values a team-based approach. “I appreciate that receiving a cancer diagnosis can be scary and stressful. I am fortunate to work with an amazing team of nurses, social workers, nutritionists, genetic counselors and many others who help to support our patients through this journey.”. Dr. Mccormick is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Bruckner did both his undergraduate and graduate work at Creighton University in Omaha, Nebraska, graduating summa cum laude with a Bachelor of Mathematics and earning magna cum laude honors from medical school. He completed his residency and served as a clinical instructor in orthopaedics with the U.S. Navy. Dr. Bruckner did his fellowship training in Seattle at Children’s Hospital and the University of Washington. While at U.W., he was an associate professor in the Department of Orthopaedics, served as Director of the hip and knee replacement service, and developed the total-joint fellowship program. He has received numerous honors, awards, and peer recognition. He was Chairman of the Overlake Hospital Department of Orthopaedics from 2006 through 2010. Dr. Bruckner is an avid gardener, musician and enjoys both snow and water skiing. Congratulations to Dr. Bruckner for being awarded Top Orthopaedic Doctor by Seattle Magazine, Seattle Met, and Consumers Checkbook in 2015!. Dr. Bruckner is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Osteoarthritis, Bone Tumor, Undifferentiated Pleomorphic Sarcoma, Knee Replacement, and Hip Replacement.

Bruce Lin, MD, specializes in hematology and medical oncology, liver cancer, colorectal cancer and other gastrointestinal cancer, gastrointestinal oncology, colorectal care, liver, cancer, pancreatic cancer, bile duct cancer, and gastroesophageal cancer.Dr. Lin enjoys basketball, golf, fishing and photography. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Ampullary Cancer, Anal Cancer, and Lynch Syndrome.

I strive to provide personalized, cutting-edge therapy in a multidisciplinary setting. I offer patients and families understandable knowledge in order for them to navigate the illness and treatment process, and to build true partnerships with compassion, empathy and respect. Dr. Xie is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Bone Marrow Aspiration.

Mandy Robertson is an Oncologist and a Hematologist in Gig Harbor, Washington. Dr. Robertson is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Intraductal Papilloma, Pleuropulmonary Blastoma, Follicular Lymphoma, and Richter Syndrome. Dr. Robertson is currently accepting new patients.

Subhash Sharma is a Hematologist Oncology specialist and a Hematologist in Mukilteo, Washington. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Sharma is currently accepting new patients.

Elizabeth Loggers is an Oncologist and a Hematologist in Seattle, Washington. Dr. Loggers is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, Angiosarcoma, and Liver Embolization. Dr. Loggers is currently accepting new patients.